Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dapagliflozin in Acute Myocardial Infarction
NCT06009874Recruiting
- Start
- Dec 2023
- Primary completion
- Oct 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in myocardial infarction (MI) comparing Dapagliflozin group with Placebo group (2 arms). Primary endpoints: Difference in infarct size at 3 months and Difference in NT-proBNP level at 3 months. Started Dec 2023; status: recruiting.
02
Drugs
dapagliflozin
03
Conditions
myocardial infarction (MI)
Beyond the preview
Go deeper on NCT06009874.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06009874.